Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas.
Pietanza, M C
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 06 2016 - 890-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1556-1380
10.1016/j.jtho.2016.02.018 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab--administration & dosage
Brain Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Paclitaxel--administration & dosage
Pemetrexed--administration & dosage
Prognosis
Proto-Oncogene Mas
Survival Rate
Phase II Study of a Non-Platinum-Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 06 2016 - 890-9 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article
1556-1380
10.1016/j.jtho.2016.02.018 doi
Adenocarcinoma--drug therapy
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab--administration & dosage
Brain Neoplasms--drug therapy
Female
Follow-Up Studies
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Paclitaxel--administration & dosage
Pemetrexed--administration & dosage
Prognosis
Proto-Oncogene Mas
Survival Rate